Generic Semaglutide in Canada
In April 2026, Canada became the first G7 country to approve generic semaglutide. Health Canada has now approved generics from Dr. Reddy's and Apotex, plus Svemia, the first generic for chronic weight management. Compare licensed Canadian providers.
Updated: October 9, 2026
Licensed Canadian clinicians · Health Canada-approved medications · Delivered to all provinces
Canada's most trusted weight loss program
$0 consultation
Generic semaglutide from $149/month
Generic semaglutide from $149/mo
Generic semaglutide from $149
$149 month 1, then $199/mo
01
Felix Health
Outstanding
Canada's most trusted weight loss program
- $0 consultation, treatment prices down 50%+*
- Canadian-licensed practitioners, fully online
- Free home delivery and ongoing care
Best Overall Pick
*Felix Health: $0 initial consultation and treatment prices have dropped by over 50%. Visit felix.ca for full details.
In April 2026, Canada became the first G7 country to approve generic semaglutide
Health Canada has approved Dr. Reddy's and Apotex generic semaglutide (Ozempic equivalents for type 2 diabetes) and Svemia by Apotex (Wegovy equivalent for chronic weight management). Health Canada estimates generics will cost 45-90% less than the brand-name version.
Key Takeaways for Canadian Patients
- 1In April 2026, Canada became the first G7 country to approve generic semaglutide. Three generic products are now authorized by Health Canada, with more submissions under review.
- 2Approved generics are bioequivalent to their brand reference (Ozempic or Wegovy), the same active molecule.
- 3Health Canada estimates 45-90% savings vs. brand-name Ozempic as the market matures over 12-24 months.
- 4Every provider here is a licensed Canadian telehealth clinic. Consultations, prescriptions, and delivery are handled entirely online.
Generic Semaglutide Providers
Health Canada Approved
Generic semaglutide from Dr. Reddy's and Apotex (Ozempic equivalents) and Svemia (Wegovy equivalent) is Health Canada-approved. Plosbrio and Poviztra are Novo Nordisk's lower-priced renamed versions of Ozempic and Wegovy, not generics.
Provider Comparison
$0 initial consultation
$0 consultation, treatment prices down 50%+* · Canadian-licensed practitioners, fully online
Visit Site →From $149/month
Generic semaglutide from $149/month · $99 consult, then $60/month program fee
Visit Site →$149 month 1, then $199/mo
Free assessment, pay only if approved · $149 month one, then $199/month all-in
Visit Site →From $99/month
100% online visit, no insurance needed · Brand-name GLP-1 injections and oral options
Visit Site →Provider | Rating | Key Features | Price | Visit |
|---|---|---|---|---|
| Felix Health | 9.9 | $0 consultation, treatment prices down 50%+*, Canadian-licensed practitioners, fully online | $0 initial consultation | Visit Site |
| MyRocky | 9.8 | Generic semaglutide from $149/month, $99 consult, then $60/month program fee | From $149/month | Visit Site |
| BirchRx | 9.7 | Free assessment, pay only if approved, $149 month one, then $199/month all-in | $149 month 1, then $199/mo | Visit Site |
| Direct Meds | 9.5 | 100% online visit, no insurance needed, Brand-name GLP-1 injections and oral options | From $99/month | Visit Site |
Generic Semaglutide in Canada: What You Need to Know
In April 2026, Canada became the first G7 country to approve generic semaglutide. Health Canada has since approved three generic products from two manufacturers, Dr. Reddy's Laboratories and Apotex Inc., and is still reviewing further submissions from companies including Sandoz, Teva, Taro and Aspen. Generics must demonstrate bioequivalence to their reference product before receiving approval.
For Canadians who have been priced out of brand-name GLP-1 medications, this approval has the potential to transform access. Health Canada has estimated that generic semaglutide will be 45-90% cheaper than brand-name Ozempic, though the full price impact will take 12-24 months to materialize as production scales and more generics enter the market.
Health Canada-Approved Generic Semaglutide Products
Dr. Reddy's generic semaglutide
Dr. Reddy's Laboratories · Ozempic equivalent
Approved April 28, 2026, the first generic semaglutide approved in the G7. Indicated for type 2 diabetes.
Apotex generic semaglutide
Apotex Inc. · Ozempic equivalent
Approved May 1, 2026. Indicated for type 2 diabetes.
Svemia
Apotex Inc. · Wegovy equivalent
Approved June 29, 2026, the first generic approved for chronic weight management (ages 12 and older).
Health Canada is still reviewing more generic submissions, including from Sandoz, Teva, Taro and Aspen. Plosbrio and Poviztra are not generics. They are Novo Nordisk's own lower-priced renamed versions of Ozempic and Wegovy, approved in December 2025.
What Does 'Generic' Actually Mean?
A Health Canada-approved generic drug must demonstrate bioequivalence to the reference product. This means it delivers the same amount of active ingredient into the bloodstream at the same rate, within an accepted statistical margin. The active molecule (semaglutide) is identical. The pen device and inactive ingredients may differ slightly, but the clinical effect is the same.
For patients currently on Ozempic, switching to a generic does not require a dose adjustment or a clinical restart. Your physician can write a new prescription for generic semaglutide, and you continue on your current dose schedule with the new product.
Frequently Asked Questions
Recommended Providers
Our editorial team’s top picks for this category.
Compare Generic Semaglutide Providers in Canada
Get Health Canada-approved generic semaglutide online, no clinic visit required.
View All ProvidersAdvertising & Affiliate Disclosure: We may receive compensation when you click on links to partners featured on this site. Our rankings and recommendations are based on our independent research methodology and editorial standards, not on sponsorship or payment. Some links are affiliate links, which means we may earn a commission at no extra cost to you if you make a purchase.
Medical Disclaimer: The content on this site is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider for medical questions, treatment decisions, or emergency care. Do not disregard professional medical advice or delay seeking it based on information found here.